tiprankstipranks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market
Holding VIR?
Track your performance easily

Vir Biotechnology (VIR) Balance Sheet

1,189 Followers

Vir Biotechnology Balance Sheet

Vir Biotechnology's total assets for Q4 2023 were $1.92B, a decrease of -6.15% from the previous quarter. VIR total liabilities were $328.82M for the fiscal quarter, a -11.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 1.92B$ 2.80B$ 1.95B$ 918.76M$ 512.07M
Total Liabilities
$ 328.82M$ 724.13M$ 522.42M$ 201.91M$ 88.13M
Total Equity Gross Minority
$ 1.59B$ 2.08B$ 1.43B$ 716.85M$ 423.94M
Total Capitalization
$ 1.70B$ 2.20B$ 1.43B$ 716.85M$ 423.94M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 70.18M$ 237.00K
Currency in USD

Vir Biotechnology Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis